Entering text into the input field will update the search result below

Sanara MedTech provides Q4 prelims

  • Sanara MedTech (NASDAQ:SMTI) expects Q4 total revenue of ~$4.8M vs. $3.4M in year ago quarter; FY20 revenue is seen rising 32%.
  • Cash and equivalents estimated at ~$0.5M as of Dec. 31, 2020.
  • The company entered into a loan agreement with

Recommended For You

More Trending News

About SMTI Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
SMTI--
Sanara MedTech Inc.